Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.
Saved in:
| Title: | Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. |
|---|---|
| Authors: | Stabile A; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Department of Urology and Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.; Division of Surgery and Interventional Science, University College London, London, UK., Orczyk C; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK., Hosking-Jervis F; Division of Surgery and Interventional Science, University College London, London, UK., Giganti F; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Arya M; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK., Hindley RG; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Dickinson L; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Allen C; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Punwani S; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Jameson C; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, UK., McCartan N; Division of Surgery and Interventional Science, University College London, London, UK., Montorsi F; Department of Urology and Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Briganti A; Department of Urology and Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Ahmed HU; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Emberton M; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK., Moore CM; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK. |
| Source: | BJU international [BJU Int] 2019 Sep; Vol. 124 (3), pp. 431-440. Date of Electronic Publication: 2019 Mar 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
